Results 151 to 160 of about 36,080 (282)

Animal models of Huntington's disease. Pros and cons. [PDF]

Brain Behav Immun Health
Stepanova P, Voutilainen MH, Eriksson O, Lindholm D.   +3 more
europepmc   +1 more source

Nonlinear Decrease over Time in N‐Acetyl Aspartate Levels in the Absence of Neuronal Loss and Increases in Glutamine and Glucose in Transgenic Huntington's Disease Mice [PDF]

, 2000
Bruce G. Jenkins, Péter Klivènyi, Ekkehard Küstermann, Ole A. Andreassen, Robert J. Ferrante, Bruce R. Rosen, M. Flint Beal   +6 more
openalex   +1 more source

Huntington Disease [PDF]

Journal of the Royal Society of Medicine, 2005
openaire   +2 more sources

Epigenetic mechanisms and therapeutic innovations in chronic pain‐associated neuropsychiatric co‐morbidities

British Journal of Pharmacology, EarlyView.
Abstract Chronic pain, marked by nociceptive sensitization and maladaptive neuroplasticity, affects 30% of the global population with escalating socioeconomic burdens. Epidemiological data show a 2‐3‐fold increase in neuropsychiatric co‐morbidities among individuals with chronic pain, where epigenetic dysregulation serves as a key mechanism linking ...
Kai Zhang, Sijia Zhu, Na Xing, Zhen Zhou, Jiayi Chen, Tianen Si, Mingrui Li, Lin Jia, Yousef Rastegar‐Kashkooli, Tom J. Wang, Wei Zhu, Jing Li, Chao Jiang, Junmin Wang, Moxin Wu, Xiaoping Yin, Weidong Zang, Jian Wang, Songxue Su   +18 more
wiley   +1 more source

Neural and biomarker correlates of the Parkinson's Disease-Cognitive Rating Scale in Huntington's disease. [PDF]

Neuroimage Rep
Martinez-Horta S, Puig-Davi A, Sampedro F, Pérez-Pérez J, Franch-Martí C, Olmedo-Saura G, Rivas-Asensio E, Vazquez-Oliver A, Pérez-Carasol L, Horta-Barba A, Pagonabarraga J, Kulisevsky J.   +11 more
europepmc   +1 more source

Implant Therapy in Patients With Neurodegenerative Diseases—A Scoping Review

Clinical Oral Implants Research, EarlyView.
ABSTRACT Objectives The increasing longevity of populations has resulted in a growing number of older adults requiring prosthodontic care, including those with neurodegenerative diseases (NDs). Neurodegenerative diseases pose significant challenges to prosthodontic care, and it remains unclear whether implant therapy in this population achieves ...
Lysandre David, Sabrina Maniewicz, Najla Chebib, Gabriel Gold, Murali Srinivasan, Frauke Müller   +5 more
wiley   +1 more source

How Early Does Anosognosia Begin in Huntington's Disease? [PDF]

Mov Disord Clin Pract
Bagga K, Xu A, Hall A, Kaur J, Gilbert PE, Corey-Bloom J.   +5 more
europepmc   +1 more source

Climate shocks, democratization and (a culture of) cooperation

Economica, EarlyView.
Abstract While the direct economic effects of adverse climate shocks are well known, their indirect institutional impact is still poorly understood. To clarify this, we test the idea that adverse climate shocks push time‐inconsistent elites to enact inclusive political institutions, and non‐elites to embrace strong norms of cooperation.
Giacomo Benati, Carmine Guerriero
wiley   +1 more source

Systematic Review with Meta-Analysis of Biofluid Markers for Huntington's Disease. [PDF]

Mov Disord
Paulsen JS, Bovin NA, Clemsen JD, Weiss A, Key AM, Janz ML, Pinto A, Burks DK, Zetterberg H, Shannon KM.   +9 more
europepmc   +1 more source

Improvements in Real‐World Survival in the Setting of a Recent Paradigm Shift in Acute Myeloid Leukemia Treatment

European Journal of Haematology, EarlyView.
ABSTRACT Therapeutic options for newly diagnosed (ND) acute myeloid leukemia (AML) have increased in recent years, leading to a shift in the treatment paradigm from conventional, intensive chemotherapy toward targeted and less intensive therapy. Since 2017, there has been a surge in FDA approvals for novel therapies, including small molecule inhibitors
Thuy N. Ho, Patrick Willard, Graeme F. Murray, Li Liu, Nolan Wages, Hyun Lee, Keri R. Maher   +6 more
wiley   +1 more source